, a manufacturer of biomedical-testing instruments and supplies, said its third-quarter earnings rose more than 30% from the year-ago period.
The company earned $47.4 million, or 74 cents a share, in the quarter, compared with $36.2 million, or 56 cents a share, a year ago. Adjusted for items, earnings were 66 cents a share in the most recent quarter, in line with analysts' estimation.
Third-quarter revenue rose 6.4% from a year ago to $631.2 million. Analysts surveyed by Thomson First Call were expecting revenue of $622.2 million. Revenue from worldwide consumables rose 13.7% in the most recent quarter.
Beckman expects to earn $2.75 a share to $2.95 a share, excluding special items, for the year. On average, analysts are looking for $2.83 a share.
This story was created through a joint venture between TheStreet.com and IRIS.